Company Overview
The company focuses on three core business areas: development of functional ingredients and finished products utilizing Actiponinⓡ, research on new health functional food ingredients, and natural drug development.
Since officially launching its overseas exports in 2016, TG Biotech has achieved rapid sales growth, recognized for the scientific efficacy and high quality of Actiponinⓡ.
Expanding its influence primarily in the U.S. market, the company is now actively pursuing export expansion into Southeast Asia and the Middle East.
Moving beyond a business model centered solely on ingredient sales, TG Biotech plans to strengthen direct consumer engagement in global markets through its proprietary health functional food brand, ActiFit.
